Product Description
The Tumor Test Marker series, models YRA385 to YRA391, represents the latest advancement in cancer detection technology. These cutting-edge diagnostic tools are designed to measure various tumor markers with high precision and reliability. Each model in the series specializes in a specific tested parameter: AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA, respectively.
Operating on the CLIA (Chemiluminescence Immunoassay) analysis mode, these tumor markers provide accurate results crucial for early diagnosis and effective treatment plans. The products are packaged conveniently in 50T/BOX, 100T/BOX, and 24T/BOX, making them adaptable to your laboratory needs. The analysis is powered by AP (Alkaline Phosphatase), ensuring optimal performance under the storage conditions of 2-8°C. Furthermore, the calibration process is streamlined with 2/6 points, ensuring consistent results and ease of use for laboratory professionals.
| Model | YRA385 | YRA386 | YRA387 | YRA388 | YRA389 | YRA390 | YRA391 |
| Tested Parameter | AFP | CEA | CA125 | CA15-3 | CA19-9 | f-PSA | t-PSA |
| Analysis Mode | CLIA | ||||||
| Package Specification | 50T/BOX, 100T/BOX, 24T/BOX | ||||||
| Platform | AP (Alkaline Phosphatase) | ||||||
| Storage | 2-8°C | ||||||
| Calibration | 2/6 Points | ||||||
| Certification | CE, ISO13485, FSC | ||||||
Market Price
The cost of Tumor Test Markers like the YRA series varies depending on the supplier and the specific packaging requirements. On average, these test kits range from $500 to $1500 per box, depending on the quantity and model selected. Considering the sophistication and precision these tests provide, they represent excellent value in the realm of cancer diagnostics, ensuring both affordability and quality.
To explore competitive pricing and take advantage of exclusive offers, potential buyers are encouraged to request a quote through Kalstein Plus. This platform facilitates an automatic quotation process, providing quick and easy access to the latest prices and availability.
Frequently Asked Questions
What is the difference between the models YRA385 to YRA391?
Each model is designed to test a specific tumor marker. YRA385 tests for AFP, YRA386 for CEA, YRA387 for CA125, YRA388 for CA15-3, YRA389 for CA19-9, YRA390 for f-PSA, and YRA391 for t-PSA.
What kind of certification do these products have?
The Tumor Test Markers carry CE, ISO13485, and FSC certifications, ensuring they meet high international standards for medical devices.
How should these products be stored?
The recommended storage conditions are between 2-8°C to maintain the integrity and effectiveness of the tests.
Advantages and Disadvantages
The primary advantage of the Tumor Test Marker series is its high precision in detecting cancer-related markers. This precision aids in the early detection of cancer, significantly improving treatment outcomes. Additionally, the CE and ISO13485 certifications assure users of the product’s compliance with international standards, adding a level of trust and reliability to the use of these markers.
However, the disadvantages may include the initial investment cost, as these products can be relatively expensive, especially for smaller labs with limited budgets. Additionally, the need for specific storage conditions may be challenging for some facilities without adequate temperature control systems.
Field Application
In practical laboratory settings, these tumor markers are employed for routine screenings and monitoring of cancer patients. They provide critical data that help oncologists track the progression of the disease and the patient’s response to treatment. The high specificity and accuracy of these tests enable healthcare providers to tailor treatment plans more effectively, improving patient outcomes.
The use of these markers is particularly common in hospitals and research institutions focused on cancer studies and diagnostics. Labs equipped with CLIA technology systems can seamlessly integrate the YRA series into their operations, enhancing their diagnostic capabilities.
Recommendations
For optimal results, it is recommended that laboratories using the Tumor Test Marker series adhere strictly to the specified storage conditions. Regular calibration, following the 2/6 points guideline, is essential to maintain test accuracy and reliability. Additionally, laboratory personnel should be adequately trained in the CLIA method to maximize the efficacy of these diagnostic tools.
Engaging with the Kalstein Plus platform can also provide valuable insights and updates, ensuring that laboratories remain at the forefront of technological advancements in cancer diagnostics.
If you’re seeking a blend of innovation and quality, you have come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each device with a level of excellence. Our intuitive and agile online purchasing channels are designed for your convenience, ensuring the most friendly prices. Don’t hesitate any longer, we bring science to life, it’s time to become part of our community. https://kalstein.net/en/product/tumor-test-marker-yra385-yra391/
